A pharma company that spent $500,000 trying to keep pot illegal just got DEA approval for synthetic marijuana

Posted on by WOCredentials

“Insys Therapeutics, a pharmaceutical company that was one of the chief financial backers of the opposition to marijuana legalization in Arizona last year, received preliminary approval from the Drug Enforcement Administration this week for Syndros, a synthetic marijuana drug.”

Read more here.

Discover more from ContraReport

Subscribe to get the latest posts sent to your email.

Related Posts

Cannabinoids and the immune system: an overview (2010)

“Cannabinoids can modulate immune reactions in the periphery but also in the brain, influence T cell subset balance and cytokine expression and play a role in the balance between neuroinflammation […]

Medical Marijuana Reduces Prescription Drug Use, Says New Research

“Medical cannabis laws are associated with significant reductions in opioid prescribing in the Medicare Part D population. This finding was particularly strong in states that permit dispensaries, and for reductions […]

Cannabinoids and the immune system: potential for the treatment of inflammatory diseases? (2011)

“Cannabinoids can modulate both the function and secretion of cytokines from immune cells. Therefore, cannabinoids may be considered for treatment of inflammatory disease.” Kozela, E., Lev, N., Kaushansky, N., Eilam, […]